Magnetic resonance imaging subgroup analysis from the TEMSO placebo-controlled phase III trial of oral teriflunomide in multiple sclerosis with relapses: O281


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles